HocusLocus Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

HocusLocus General Information

Description

Developer of a cell line selection technology designed to exploit the post-transcriptional regulation of RNA. The company's technology offers a diagnostic kit for researching on RNA, enabling researchers to detect the real-time production of specific miRNAs in living cells without destroying them in the process.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 22 Valleyview Drive
  • Albany, NY 12208
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 22 Valleyview Drive
  • Albany, NY 12208
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HocusLocus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 10-Jan-2020 Completed Out of Business
5. Grant 01-Jan-2017 Completed Product Development
4. Grant 01-Jan-2015 Completed Product Development
3. Grant 01-Mar-2014 Completed Product Development
2. Early Stage VC 01-Jan-2013 Completed Product Development
1. Grant 01-Jan-2011 $294K Completed Startup
To view HocusLocus’s complete valuation and funding history, request access »

HocusLocus Patents

HocusLocus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3201337-A1 Methods and compositions for use of non-coding rna in cell culturing and selection Inactive 03-Oct-2014
US-11254935-B2 Methods and compositions for use of non-coding rna in cell culturing and selection Active 03-Oct-2014
US-20170298350-A1 Methods and compositions for use of non-coding rna in cell culturing and selection Active 03-Oct-2014
EP-3201337-A4 Methods and compositions for use of non-coding rna in cell culturing and selection Inactive 03-Oct-2014
US-20160369271-A1 Methods of using structurally interacting rna Inactive 17-Sep-2013 C12N15/113
To view HocusLocus’s complete patent history, request access »

HocusLocus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HocusLocus Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute Of Allergy and Infectious Diseases Government
To view HocusLocus’s complete investors history, request access »

HocusLocus FAQs

  • When was HocusLocus founded?

    HocusLocus was founded in 2007.

  • Who is the founder of HocusLocus?

    Jamie Keith Ph.D is the founder of HocusLocus.

  • Where is HocusLocus headquartered?

    HocusLocus is headquartered in Albany, NY.

  • What is the size of HocusLocus?

    HocusLocus has 3 total employees.

  • What industry is HocusLocus in?

    HocusLocus’s primary industry is Biotechnology.

  • Is HocusLocus a private or public company?

    HocusLocus is a Private company.

  • What is HocusLocus’s current revenue?

    The current revenue for HocusLocus is .

  • Who are HocusLocus’s investors?

    National Institute Of Allergy and Infectious Diseases has invested in HocusLocus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »